Federal grants to Aronora Inc
Aronora Inc in Portland, Oregon received $12.0 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Cardiovascular Diseases Research, with $12.0 million. In fiscal 2025 it was awarded $2.4 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$12.0 million
- Awards5
- Awarded in FY 2025$2.4 million
- Largest award$3.8 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $2.0 million |
| FY 2022 | 3 | $2.3 million |
| FY 2023 | 3 | $2.7 million |
| FY 2024 | 3 | $2.6 million |
| FY 2025 | 2 | $2.4 million |
Programs that fund Aronora Inc
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 5 | $12.0 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $12.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Contact pathway inhibitor to prevent vascular access failure - project summary end-stage renal disease (ESRD) patients must maintain chronic vascular access to perform life-saving hemodialysis (HD); however, the hd access portal is extremely vulnerable to infection, stenosis, and thrombo- occlusion. | Cardiovascular Diseases Research | May 24, 2023 | $3.8 million |
| Antithrombotic protein c activator for hemodialysis | Cardiovascular Diseases Research | March 26, 2021 | $3.0 million |
| Hls- factor xii inhibitor for surface initiated thrombosis | Cardiovascular Diseases Research | February 27, 2021 | $1.9 million |
| Thrombopoietin targeting in myeloproliferative neoplasms - project summary/abstract treatment of patients with myeloproliferative neoplasms (MPNS) is limited to palliative and cytoreductive agents that mitigate proliferative blood counts and their effects. Small molecule selective tyrosine kinase (j | Cardiovascular Diseases Research | April 22, 2022 | $1.7 million |
| Contact pathway inhibitor to prevent catheter-related thrombosis - project summary indwelling central venous catheters (CVCS), including peripherally inserted central catheters (PICCS) as well as implantable venous access ports, are commonly used for drug treatments or supportive care in a variety o | Cardiovascular Diseases Research | June 6, 2024 | $1.6 million |
Questions people ask
How much federal grant money does Aronora Inc get?
$12.0 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Aronora Inc the most?
The Department of Health and Human Services, with $12.0 million in 5 awards.
What is Aronora Inc's largest federal grant?
$3.8 million under Cardiovascular Diseases Research, with its first action in the period on May 24, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in Portland
- Oregon Health & Science University
- Tri-County Metropolitan Transportation District of Oregon
- Oregon Department of Housing & Community Services
- Mercy Corps
- Pacific States Marine Fisheries Commission
- Oregon Department of Environmental Quality
- Port of Portland
- Portland State University
Largest federal grant recipients in Oregon · Federal grants in Oregon